Norges Bank Sangamo Therapeutics, Inc Transaction History

Norges Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 08, 2020	SELL	$5.05 - $8.85 $50,500 - $88,500	-10,000 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$8.03 - $11.7 $80,300 - $117,000	10,000 New	10,000 $84,000
Q4 2019 Feb 12, 2020	SELL	$8.03 - $11.7 $80,300 - $117,000	-10,000 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$9.05 - $12.22 $90,500 - $122,200	10,000 New	10,000 $91,000
Q3 2019 Nov 08, 2019	SELL	$9.05 - $12.22 $90,500 - $122,200	-10,000 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$8.75 - $13.03 $87,500 - $130,300	10,000 New	10,000 $108,000

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $387M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.